Measurable Residual Disease Monitoring in Lymphoma

Cuzzo, B., Lipsky, A., & Cherng, H.-J. J. (2023). Measurable Residual Disease Monitoring in Lymphoma. Current Hematologic Malignancy Reports, 18(6), 292–304. https://doi.org/10.1007/s11899-023-00715-6
Authors:
Brian Cuzzo
Andrew Lipsky
Hua-Jay J Cherng
Affiliated Authors:
Brian Cuzzo
Andrew Lipsky
Hua-Jay J Cherng
Columbia Affiliation:
Subjects:
Lymphoma (MeSH)
Circulating Tumor DNA (MeSH)
Author Keywords:
circulating tumor dna
lymphoma
measurable residual disease
next generation sequencing
prognostic
response adapted
elink
Publication Type:
Article
Unique ID:
10.1007/s11899-023-00715-6
PMID:
37930608
DOI:
10.1007/s11899-023-00715-6
Journal:
Current Hematologic Malignancy Reports
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: